Guardant Health Inc

NASDAQ:GH 4:00:00 PM EDT

22.98

-1.35 (-5.55%)

7:57:37 PM EDT: $23.08 +0.10 (+0.44%)

Products

Guardant Health Receives FDA Approval For Guardant360 CDX

Published: 01/30/2023 12:27 GMT

Guardant Health Inc (GH) - Guardant Health Receives FDA Approval for Guardant360® Cdx As Companion Diagnostic for Menarini Group’s Orserdu™ for Treatment of Patients With Esr1 Mutations in Er+, Her2- Advanced Or Metastatic Breast Cancer.